STOCK TITAN
  1. Home
  2. News
  3. CRMD
  4. CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference

CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company specializing in therapeutic products for life-threatening diseases, has announced its participation in the upcoming Jefferies Global Healthcare Conference. The event will be held in New York from June 3-5, 2025. The company is scheduled to deliver a presentation on Thursday, June 5, 2025, at 3:45 p.m. EDT. A webcast of the presentation will be made available for interested parties.
CorMedix Inc. (NASDAQ: CRMD), un'azienda biofarmaceutica specializzata in prodotti terapeutici per malattie gravi, ha annunciato la sua partecipazione alla prossima Jefferies Global Healthcare Conference. L'evento si terrà a New York dal 3 al 5 giugno 2025. L'azienda presenterà giovedì 5 giugno 2025 alle 15:45 EDT. Sarà disponibile una trasmissione in webcast della presentazione per gli interessati.
CorMedix Inc. (NASDAQ: CRMD), una compañía biofarmacéutica especializada en productos terapéuticos para enfermedades graves, ha anunciado su participación en la próxima Conferencia Global de Salud de Jefferies. El evento se llevará a cabo en Nueva York del 3 al 5 de junio de 2025. La empresa realizará una presentación el jueves 5 de junio de 2025 a las 3:45 p.m. EDT. Se ofrecerá una transmisión en webcast de la presentación para quienes estén interesados.
치명적인 질병 치료 제품을 전문으로 하는 바이오제약 회사 CorMedix Inc. (NASDAQ: CRMD)이 다가오는 Jefferies 글로벌 헬스케어 컨퍼런스에 참가한다고 발표했습니다. 행사는 2025년 6월 3일부터 5일까지 뉴욕에서 개최됩니다. 회사는 2025년 6월 5일 목요일 오후 3시 45분(EDT)에 발표를 진행할 예정입니다. 관심 있는 분들을 위해 발표 웹캐스트가 제공될 예정입니다.
CorMedix Inc. (NASDAQ : CRMD), une société biopharmaceutique spécialisée dans les produits thérapeutiques pour les maladies graves, a annoncé sa participation à la prochaine conférence mondiale sur la santé Jefferies. L'événement se tiendra à New York du 3 au 5 juin 2025. L'entreprise présentera le jeudi 5 juin 2025 à 15h45 EDT. Une diffusion en webcast de la présentation sera disponible pour les intéressés.
CorMedix Inc. (NASDAQ: CRMD), ein biopharmazeutisches Unternehmen, das sich auf therapeutische Produkte für lebensbedrohliche Krankheiten spezialisiert hat, hat seine Teilnahme an der bevorstehenden Jefferies Global Healthcare Conference angekündigt. Die Veranstaltung findet vom 3. bis 5. Juni 2025 in New York statt. Das Unternehmen wird am Donnerstag, den 5. Juni 2025, um 15:45 Uhr EDT eine Präsentation halten. Für Interessierte wird ein Webcast der Präsentation verfügbar sein.
Positive
  • None.
Negative
  • None.

BERKELEY HEIGHTS, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, will be participating in the Jefferies Global Healthcare Conference, taking place in New York on June 3 - 5, 2025.

Jefferies Global Healthcare Conference
Date:Thursday, June 5, 2025
Time:3:45p.m. EDT
Format:Presentation
Webcast:Link

About CorMedix

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath® (taurolidine and heparin) which was approved by the FDA on November 15, 2023. CorMedix commercially launched DefenCath in inpatient settings in April 2024 and in outpatient settings in July 2024. CorMedix is commencing clinical studies in adult Total Parenteral Nutrition (TPN) patients and pediatric hemodialysis (HD) patient populations in 2025 and also intends to develop DefenCath as a catheter lock solution for use in other therapeutic areas. For more information visit: www.cormedix.com. 

Investor Contact:
Dan Ferry
Managing Director
LifeSci Advisors
daniel@lifesciadvisors.com 
(617) 430-7576


FAQ

When is CorMedix (CRMD) presenting at the Jefferies Global Healthcare Conference 2025?

CorMedix is scheduled to present on Thursday, June 5, 2025, at 3:45 p.m. EDT.

Where is the Jefferies Global Healthcare Conference 2025 being held?

The conference is taking place in New York from June 3-5, 2025.

What type of company is CorMedix (CRMD)?

CorMedix is a biopharmaceutical company that develops and commercializes therapeutic products for life-threatening diseases and conditions.

What is the format of CorMedix's participation at the Jefferies Healthcare Conference?

CorMedix will be delivering a presentation at the conference, which will be available via webcast.
Stock CRMD logo
Cormedix

NASDAQ:CRMD

CRMD Rankings

#2654 Ranked by Market Cap
N/A Ranked by Dividends

CRMD Latest News

May 15, 2025
CorMedix Inc. to Participate in the RBC Global Healthcare Conference
May 6, 2025
CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
Apr 29, 2025
CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025
Apr 8, 2025
Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance
Apr 2, 2025
CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

CRMD Stock Data

831.53M
67.02M
1.25%
39.99%
12.98%
Biotechnology
Pharmaceutical Preparations
Link
United States
BERKELEY HEIGHTS

Related Articles

Continue reading with these related stories

View All Latest News